The proposed research involves the development of many new C-C and C-N bond forming reactions for eventual application to the total synthesis of pharmacologically significant materials, specifically: a) Stereocontrolled additions of various allyltin reagents to Beta-alkoxyaldehydes; b) Stereocontrolled additons of various allyltin reagents to Alpha-alkoxyaldehydes, c) Stereocontrolled additions of various allyltin reagents to Alpha-Beta-dialkoxyaldehydes, with stereochemical control formally exerted by either the Alpha or Beta-alkoxy group, d) The extension of the chemistry above aldimines, and Alpha and Beta-alkoxy aldimines. e) Asymmetric synthesis of homoallyl amines from readily available chiral aldimines, f) Further studies on new """"""""one electron"""""""" C-C bond forming processes, g) Stereocontrolled additions of heteroatom or carbon nucleophiles to various Gamma-substituted unsaturated ketones, estaers, and thiol esters, h) Mechanistic investigations of the factors controlling the above processes, and i) Application of the foregoing to the synthesis of medicinally important materials, specifically pyrrolizidne alkaloids, calcimycin, the herbimycins and macbecins, and the mitomycins. It should be noted that perhaps the most significant aspect of the proposed work is its almost universal applicability to the synthesis of biologically active materials.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM028961-06
Application #
3276353
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1981-06-01
Project End
1988-05-31
Budget Start
1986-06-01
Budget End
1987-05-31
Support Year
6
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
Schools of Arts and Sciences
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Petersen, Mark E; Kedei, Noemi; Lewin, Nancy E et al. (2016) Replacement of the Bryostatin A- and B-Pyran Rings With Phenyl Rings Leads to Loss of High Affinity Binding With PKC. Tetrahedron Lett 57:4749-4753
Kelsey, Jessica S; Cataisson, Christophe; Chen, Jinqiu et al. (2016) Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin. Mol Carcinog 55:2183-2195
Kedei, Noemi; Kraft, Matthew B; Keck, Gary E et al. (2015) Neristatin 1 provides critical insight into bryostatin 1 structure-function relationships. J Nat Prod 78:896-900
Kraft, Matthew B; Poudel, Yam B; Kedei, Noemi et al. (2014) Synthesis of a des-B-ring bryostatin analogue leads to an unexpected ring expansion of the bryolactone core. J Am Chem Soc 136:13202-8
Kedei, Noemi; Chen, Jin-Qiu; Herrmann, Michelle A et al. (2014) Molecular systems pharmacology: isoelectric focusing signature of protein kinase C? provides an integrated measure of its modulation in response to ligands. J Med Chem 57:5356-69
Kedei, N; Telek, A; Michalowski, A M et al. (2013) Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action. Biochem Pharmacol 85:313-24
Keck, Gary E; Poudel, Yam B; Rudra, Arnab et al. (2012) Role of the C8 gem-dimethyl group of bryostatin 1 on its unique pattern of biological activity. Bioorg Med Chem Lett 22:4084-8
Keck, Gary E; Poudel, Yam B; Cummins, Thomas J et al. (2011) Total synthesis of bryostatin 1. J Am Chem Soc 133:744-7
Kedei, Noemi; Telek, Andrea; Czap, Alexandra et al. (2011) The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line. Biochem Pharmacol 81:1296-308
Keck, Gary E; Poudel, Yam B; Rudra, Arnab et al. (2010) Molecular modeling, total synthesis, and biological evaluations of C9-deoxy bryostatin 1. Angew Chem Int Ed Engl 49:4580-4

Showing the most recent 10 out of 32 publications